Sunesis Collaboration Technology. All right, title, and interest in and to the Sunesis Collaboration Technology shall be owned by Sunesis, subject to the licenses granted to Biogen Idec under Article 6.
Appears in 3 contracts
Samples: Collaboration Agreement (Sunesis Pharmaceuticals Inc), Collaboration Agreement (Sunesis Pharmaceuticals Inc), Collaboration Agreement (Sunesis Pharmaceuticals Inc)
Sunesis Collaboration Technology. All Subject to Section 9.1.1(a), all right, title, and interest in and to the Sunesis Collaboration Technology shall be owned by Sunesis, subject to the licenses granted to Biogen Idec Millennium under Article 65.
Appears in 3 contracts
Samples: License Agreement (Sunesis Pharmaceuticals Inc), License Agreement (Sunesis Pharmaceuticals Inc), License Agreement (Sunesis Pharmaceuticals Inc)
Sunesis Collaboration Technology. All Subject to Section 9.1.1(a), all right, title, and interest in and to the Sunesis Collaboration Technology shall be owned by Sunesis, subject to the licenses granted to Biogen Idec DOT-1 under Article 65.
Appears in 2 contracts
Samples: License Agreement for Raf (Viracta Therapeutics, Inc.), License Agreement for Raf (Day One Biopharmaceuticals Holding Co LLC)
Sunesis Collaboration Technology. All right, title, and interest in and to the Sunesis Collaboration Technology shall be owned by Sunesis, subject to the licenses granted to Biogen Idec Millennium under Article 64.
Appears in 1 contract
